Advanced/Specific Search Results HCV polymerase inhibitor pro-drug

Home

Results

Protocol Registry

Trial Results

IFPMA

Background

Links

About this Registry

This database is populated with information on the results of Roche-sponsored clinical trials.

What are the differences between clinical trial phases?

Why has Roche decided to have its own registry and results database?

More FAQs

Glossary of Terms

Phase Definitions

Field Definitions

Clinical Trial Policy

Site Provided by Thomson CenterWatch

Clinical Trial Results: HCV polymerase inhibitor pro-drug

Product Name: HCV polymerase inhibitor pro-drug
Date of Report: To be Published
Phase: II
APOLLO Study: A Study of HCV Polymerase Inhibitor Pro-Drug in Combination With PEGASYS With or Without COPEGUS in Patients With Chronic Hepatitis C Genotype 1 Infection.

Product Name: HCV polymerase inhibitor pro-drug
Date of Report: To be Published
Phase: II
A Study of HCV Polymerase Inhibitor Pro-Drug in Combination With PEGASYS® Plus COPEGUS Compared With PEGASYS® Plus COPEGUS in Patients With Chronic Hepatitis C Genotype 1 Infection.


© 1996-2008 F.Hoffmann-La Roche Ltd See our legal Statement

Home

Trial Results updated: July 24, 2008 at 1:15:34 PM